A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years

• DOI: 10.1007/s00787-017-1054-3
• Publication Date: 2017-10-30T01:39:41Z
• Authors: Edmund J. S. Sonu...; Joanne Barton; David Daley; Judy Hutchings; Tom Maishman; James Raftery; Louise Stanton; Cathy Laver-Bradbury; Maria Chorozoglou; David Coghill; Louisa Little; Martin Ruddock; Mike Radford; Guiqing Lily Yao; Louise Lee; Lisa Gould; Lisa Shipway; Pavlina Markomichali; James McGuirk; Michelle Lowe; Elvira Perez; Joanna Lockwood; Margaret J. J. Th...
• Keywords: Parent training

The objective of this study is to compare the efficacy and cost specialised individually delivered parent training (PT) for preschool children with attention-deficit/hyperactivity disorder (ADHD) against generic group-based PT treatment as usual (TAU). This a multi-centre three-arm, parallel group randomised controlled trial conducted in National Health Service Trusts. participants included were (33–54 months) fulfilling ADHD research diagnostic criteria. New Forest Parenting Programme (NFPP)—12-week individual, home-delivered programme; Incredible Years (IY)—12-week group-based, programme initially designed behaviour problems interventions. Primary outcome—Parent ratings child's symptoms (Swanson, Nolan & Pelham Questionnaire—SNAP-IV). Secondary outcomes—teacher (SNAP-IV) direct observations parent/teacher conduct problems. NFPP, IY TAU outcomes measured at baseline (T1) post (T2). NFPP only 6 months (T3). Researchers, but not therapists or parents, blind allocation. Analysis employed mixed effect regression models (multiple imputations). Intervention other costs estimated using standardized approaches. did differ on parent-rated SNAP-IV, combined [mean difference − 0.009 95% CI (− 0.191, 0.173), p = 0.921] any measure. Small, non-significant, benefits over seen [− 0.189 0.380, 0.003), 0.053]. significantly reduced compared across scales (p values < 0.05). No significant SNAP, 0.16 0.37, 0.04), 0.121] > per family providing was lower than (£1591 versus £2103). Although, there no differences between regards clinical effectiveness, less. However, may be when implemented routine practice. Clinical decisions should take into account parental preferences delivery